New class of drugs prevents significant aging mechanism in organ transplants

New class of drugs prevents significant aging mechanism in organ transplants

Athens, Greece (ots/PRNewswire) – A new study has shown that Senolytics, a new class of drugs, has the potential to prevent the transmission of senescence, a key mechanism of aging, in recipients of older donor organs. Groundbreaking research presented today at the European Society for Organ Transplantation (ESOT) 2023 Congress opens promising avenues for expanding … Read more

Bayer CEO Bill Anderson Faces Pressure to Improve Financial Performance

Bayer CEO Bill Anderson Faces Pressure to Improve Financial Performance

Bill Anderson The new Bayer boss is under pressure to deliver significantly better numbers again in 2024. (Photo: Reuters) Düsseldorf The first fiscal year of the new Bayer boss Bill Anderson will be an unusually bad one for the pharmaceutical company: the net debt will rise again significantly to 36 billion euros by the end … Read more

HANQUYOU celebrates its 3rd anniversary with impressive performances

New class of drugs prevents significant aging mechanism in organ transplants

Shanghai (ots/PRNewswire) – HANQUYOU (trastuzumab, trade names in Europe: Zercepac®; trade names in Australia: Tuzucip® and Trastucip®), the first trastuzumab biosimilar developed in China to be independently developed by Shanghai Henlius Biotech, Inc. (2696.HK), is celebrating 3 year anniversary . HANQUYOU is now indicated for the treatment of HER2-positive early breast cancer and gastric cancer. … Read more

Losan Pharma’s Expansion Continues with New Administration Building at Breisgau Business Park

Losan Pharma’s Expansion Continues with New Administration Building at Breisgau Business Park

The Neuchâtel pharmaceutical producer Losan continues to grow. The new administration building in the Breisgau business park was recently put into operation. A three-digit million amount was invested in the new building. At the headquarters in Neuenburg am Rhein, Losan Pharma GmbH, which produces for leading and internationally active pharmaceutical manufacturers, has long since reached … Read more

Biontech will remain an independent company in the future

Biontech will remain an independent company in the future

RTL>regional-news> 13. June 2022 – 12:31 pm watch – Mainz (dpa) – According to company boss Ugur Sahin, the corona vaccine manufacturer Biontech will remain independent. “There is no reason for me to assume anything else,” he told the “Handelsblatt” (Monday). Ultimately, this is a question for the major shareholders. He himself assumes that he … Read more

Biontech boss Ugur Sahin criticizes the lack of a vaccination strategy

Biontech boss Ugur Sahin criticizes the lack of a vaccination strategy

Ugur Sahin The founder and CEO of Biontech talks about his successes, visions – and bureaucracy. – (Foto: imago images/Political-Moments) – – – – Mainz The warnings of increasing numbers of corona infections due to the new variant BA.5 are getting louder. However, Biontech boss Ugur Sahin believes that a wave in the summer, if it … Read more

Measures against breast cancer – Ocuphire Pharma

Measures against breast cancer – Ocuphire Pharma

Spectrum Vision Partners and OCLI Vision believe in helping improve the communities in which we work. Our team and partners believe in promoting better health and wellness for all patients and society at large. Part of building better wellness is contributing to various causes. This October is Breast Cancer Awareness Month and we want to … Read more

Virinnox brings immediate antibody tests to pharmacies

Virinnox brings immediate antibody tests to pharmacies

Get your antibody status quickly and easily Vienna, Linz (OTS) – Recovered people, but also those who have been vaccinated, want to know how resistant their body is after having suffered a COVID illness or a vaccination. Healthcare specialist Virinnox is now ensuring that the antibody status is determined quickly. Simply go to selected pharmacies … Read more

Company: Pharmaceutical giant Johnson & Johnson announces change of boss – economy

Company: Pharmaceutical giant Johnson & Johnson announces change of boss – economy

His successor was Joaquin Duato, who like Gorsky has worked for the group for over three decades and has long been a top management. Duato is currently the Vice Chairman of the Executive Committee of Johnson & Johnson. He should also move into the administrative board, which is superordinate to the executive board. – .

European Hematology Association: Ibrutinib + venetoclax as first line treatment for chronic lymphocytic leukemia

New class of drugs prevents significant aging mechanism in organ transplants

small cell lymphocytic lymphoma works better than chlorambucil + obinutuzumab THE HAGUE, Netherlands, Feb. 6 / PRNewswire / – The combination of ibrutinib and venetoclax may be effective in patients with chronic lymphocytic leukemia / small cell lymphocytic lymphoma (CLL / SLL) due to the complementary mechanisms of action of the two target therapies. Ibrutinib … Read more